Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFALIZUMAB vs EFAVIRENZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFALIZUMAB vs EFAVIRENZ: Safety Overview

Metric EFALIZUMAB EFAVIRENZ
Total FAERS Reports 230 7,893
Deaths Reported 73 962
Death Rate 31.7% 12.2%
Hospitalizations 44 1,528
Average Patient Age 52.3 yrs 40.7 yrs
% Female Patients 46.2% 37.7%
FDA Approval Date N/A Apr 27, 2018
Manufacturer N/A Camber Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued